Articles published by Neurogene Inc.![]()
Neurogene to Participate in Upcoming Conferences
June 05, 2024
From Neurogene Inc.
Via Business Wire
Tickers
NGNE
![]()
Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome Selected by FDA for START Pilot Program
June 03, 2024
From Neurogene Inc.
Via Business Wire
Tickers
NGNE
![]() ![]() ![]() ![]()
Neurogene Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Updates
March 18, 2024
From Neurogene Inc.
Via Business Wire
Tickers
NGNE
![]() ![]()
Neurogene to Participate in Upcoming Investor Conferences
February 29, 2024
From Neurogene Inc.
Via Business Wire
Tickers
NGNE
![]() ![]()
Neurogene Announces Business Update and 2024 Outlook
January 05, 2024
From Neurogene Inc.
Via Business Wire
Tickers
NGNE
![]() ![]() ![]() ![]() ![]() ![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|